Comparison of the melanogenesis in human black and light brown melanocytes

Journal of Dermatological Science

Volumn 14, Issue 3, 1997, Pages 199-206

  Maeda, Kazuhisa ^a   Yokokawa, Yoshihiro ^a   Hatao, Masato ^a   Naganuma, Masako ^a   Tomita, Yasushi ^b  

^a SHISEIDO RESEARCH CENTER   (Japan)

^b AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Catechol O methyltransferase; Dopachrome tautomerase; ESR; Melanin; Tyrosinase; Tyrosinase related protein 1

Indexed keywords

MELANIN; MONOPHENOL MONOOXYGENASE;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MALE; MELANOCYTE; MELANOGENESIS; NEWBORN; NORMAL HUMAN; PRIORITY JOURNAL;

AFRICAN CONTINENTAL ANCESTRY GROUP; ASIAN CONTINENTAL ANCESTRY GROUP; BLOTTING, NORTHERN; CATECHOL O-METHYLTRANSFERASE; CELLS, CULTURED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ELECTRON SPIN RESONANCE SPECTROSCOPY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMANS; INFANT, NEWBORN; INTRAMOLECULAR OXIDOREDUCTASES; ISOMERASES; MALE; MELANINS; MELANOCYTES; MEMBRANE GLYCOPROTEINS; MONOPHENOL MONOOXYGENASE; OXIDOREDUCTASES; PROTEINS; RNA, MESSENGER; SKIN PIGMENTATION;

EID: 0031106753     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-1811(96)00575-0     Document Type: Article

References (34)

1. [1] Pomerantz SH: The tyrosine hydroxylase activity of mammalian tyrosinase. J Biol Chem 241: 161-168, 1966.
2. [2] Körner A, Pawelek J: Mammalian tyrosinase catalyzes three reactions in the biosynthesis of melanin. Science 217: 1163-1165, 1982.
3. [3] Körnor AM, Gettins P: Synthesis in vitro of 5,6-dihydroxyindole-2-carboxylic acid by dopachrome conversion factor from Cloudman S91 melanoma cells. J Invest Dermatol 85: 229-231, 1985.
4. [4] Aroca P, García-Borrón JC, Solano F, Lozano JA: Regulation of mammalian melanogenesis. I: Partial purification and characterization of a dopachrome converting factor: DOPAchrome tautomerase. Biochim Biophys Acta 1035: 266-275, 1980.
5. [5] Halaban R, Moellman G: Murine and human b locus pigmentation genes encode glycoprotein (gp75) with catalase activity. Proc Natl Acad Sci USA 266: 1147-1156, 1990.
6. [6] Jiménez M, Tsukamoto K, Hearing VJ: Tyrosinases from two different loci are expressed by normal and by transformed melanocytes. J Biol Chem 266: 1147-1156, 1991.
7. [7] Winder AJ, Wittbjer A, Rosengren E, Rorsman H: The mouse brown (b) locus protein has dopachrome tautomerase activity and is located in lysosomes in transfected fibroblasts. J Cell Sci 106: 153-166, 1993.
8. [8] Zhao H, Zhao Y, Nordlund JJ, Boissy RE: Human TRP-1 has tyrosine hydroxylase but no DOPA oxidase activity. Pigment Cell Res 7: 131-140, 1994.
9. [9] Kobayashi T, Urabe K, Winder A, Jiménez-Cervantes C, Imokawa G, Brewington T, Solano F, Garcia-Borrón JC, Hearing VJ: Tyrosinase related protein 1 (TRP1) functions as a DHICA oxidase in melanin biosynthesis. EMBO J 12: 5818-5825, 1994.
10. [10] Maeda K, Tomita Y, Fukuda M, Tagami H: Effects of staurosporine, PMA and A23187 on human melanocyte cultures with dibutyryl cyclic AMP. Br J Dermatol 126: 118-124, 1992.
11. [11] Martinez-Liarte JH, Solano F, Garcia-Borrón JC, Jara JR, Lozano JA: αMSH and other melanogenic activators mediate opposite effects on tyrosinase and DOPAchrome tautomerase in B16/F10 mouse melanoma cells. J Invest Dermatol 99: 435-438, 1993.
12. [12] Bouchard B, Del Marmol V, Jackson IJ, Cherif D, Dubertret L: Molecular characterization of a human tyrosinase-related protein 2 cDNA. Patterns of expression in melanocytic cells. Eur J Biochem 219: 127-134, 1994.
13. [13] Kameyama K, Sakai C, Kuge S, Nishiyama S, Tomita Y, Ito S, Wakamatsu K, Hearing VJ: The expression of tyrosinase, tyrosinase related 1 and 2 (TRP1 and TRP2), the silver protein, and a melanogenic inhibitor in human melanoma cells of differing melanogenic activities. Pigment Cell Res 8: 97-104, 1995.
14. [14] Abdel-Malek Z, Swope V, Smalara D, Babcock G, Dawes S, Nordlund JJ: Analysis of the UV-induced melanogenesis and growth arrest of human melanocytes. Pigment Cell Res 7: 326-332, 1994.
15. [15] Roméro C, Aberdam E, Larnier C, Ortonne JP: Retinoic acid as modulator of UVB-induced melanocyte differentiation. J Cell Sci 107: 1095-1103, 1994.
16. [16] Ikeda T, Sai M, Fujiwara K, Honjoh T, Hashizume S: Serum-free medium for normal human melanocytes. Anim Cell Technol Basic Appl Asp 6: 345-349, 1994.
17. [17] Wakamatsu K, Ito S: Preparation of eumelanin-related metabolites 5,6-dihydroxyindoles, 5,6-dihydroxyindole-2-carboxylic acid, and the O-methyl derivatives. Anal Biochem 170: 335-340, 1988.
18. [18] Benigni JD, Minnis RL: The synthesis of 5,6-dihydroxyindole and some of its derivatives (1). J Heterocycl Chem 2: 387-392, 1965.
19. [19] Maeda K, Fukuda M: Arbutin: mechanism of its depigmenting action in human melanocyte culture. J Pharmacol Exp Ther 276: 765-769, 1996.
20. [20] Tomita Y, Maeda K, Tagami H: Melanocyte-stimulating properties of arachidonic acid metabolites: possible role in postinflammatory pigmentation. Pigment Cell Res 5: 357-361, 1992.
21. [21] Hansson C: 6-Hydroxy-5-methoxyindole-2-carboxylic acid in normal urine. Acta Derm-Venereol (Stockh) 64: 185-190, 1984.
22. [22] Pennings EJM, van Kempen GMJ: Assay of catechol-O-methyltransferase by determination of the m-and p-O-methylated products using high performance liquid chromatography. Anal Biochem 98: 452-454, 1979.
23. [23] Sealy RC, Felix CC, Hyde JS, Swartz HM: Structure and reactivity of melanins: Influence of free radicals and metal ions. In Free Radicals in Biology. Vol. 4. Edited by WA Pryor. Academic Press, New York, 1980, pp. 209-259.
24. [24] Sealy RC, Hyde JS, Felix CC, Menon IA, Prota G: Eumelanins and pheomelanins: characterization by electron spin resonance spectroscopy. Science 217: 545-547, 1982.
25. [25] Pawelek JM, Chakraborty AK, Osber M, Grove K, Min K, Myerson N, Orlow S, Bolognia J: Stablins: ubiquitous indole stabilizing factors. Pigment Cell Res 5: 91a, 1992.
26. [26] Wilczek A, Mishima Y: Regulatory factors for polymerization of melanin monomers within corted vesicles and premelanosomes in melanoma cells. Melanoma Res 3: 255-262, 1993.
27. [27] Ito S: Reexamination of structure of eumelanin. Biochim Biophys Acta 883: 155-161, 1986.
28. [28] Palumbo A, d'Ischia M, Misuraca G, Prota G: Effect of metal ions on the rearrangement of dopachrome. Biochim Biophys Acta 925: 203-209, 1987.
29. [29] Leonard LJ, Townsend D, King RA: Function of dopachrome oxidoreductase and metal ions in dopachrome conversion in the eumelanin pathway. Biochemistry 27: 6156-6159, 1988.
30. [30] Pawelek JM: Dopachrome conversion factor functions as an isomerase. Biochem Biophys Res Commun 166: 1328-1333, 1990.
31. [31] Pawelek JM: After dopachrome? Pigment Cell Res 4: 53-62, 1991.
32. [32] Aroca P. Solano F, Salinas C, Garcia-Borron JC, Lozano JA: Regulation of the final phase of mammalian melanogenesis: the role of dopachrome tautomerase and the ratio between 5,6-dihydroxyindole-2-carboxylic acid and 5,6-dihydroxyindole. Eur J Biochem 208: 155-163, 1992.
33. [33] Orlow SJ, Osber MP, Pawelek JM: Synthesis and characterization of melanins from dihydroxyindole-2-carboxylic acid and dihydroxyindole. Pigment Cell Res 5: 113-121, 1992.
34. [34] Chakraborty A, Mishima Y, Inazu M: Melanogenic regulatory factors in coated vesicles from melanoma cells. J Invest Dermatol 93: 616-620, 1989.